Dose-dependent noradrenergic and serotonergic properties of venlafaxine in animal models indicative of antidepressant activity
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
The present study was undertaken to investigate thoroughly the preclinical psychopharmacological profile of venlafaxine, testing a wide range of doses in animal models indicative of antidepressant-like effects. Venlafaxine was found to be active in mouse forced swimming test (at 8, 16, 32 and 64 mg/kg) and to increase spontaneous locomotor activity (at 16, 32 and 64 mg/kg). Venlafaxine antagonised apomorphine-induced (16 mg/kg) hypothermia (at 2, 4, 8, 16, 32 and 64 mg/kg). Pretreatment with PCPA significantly attenuated the anti-immobility effects of venlafaxine (8 and 16mg/kg; P< 0.01) in the mouse forced swimming test. Venlafaxine at a dose of 32 mg/kg remained active, despite PCPA pretreatment. DSP-4 significantly attenuated the anti-immobility effects of venlafaxine (16 mg/kg; P < 0.05), whereas venlafaxine at 32 mg/kg remained active, despite DSP-4 pretreatment. Venlafaxine was active in the forced swimming test when administered at sub-effective doses in combination with (+/-) pindolol (venlafaxine: 1 and 2 mg/kg), RU 24969 (venlafaxine: 1, 2 and 4 mg/kg), 8-OH-DPAT (venlafaxine: 4 mg/kg), clonidine (venlafaxine: 1, 2 and 4 mg/kg), lithium (venlafaxine: 1, 2, and 4 mg/kg) and quinine (venlafaxine: 1 and 2 mg/kg). Prior administration with NAN-190 antagonised the anti-immobility effects of venlafaxine (8, 16 and 32 mg/kg). Interaction studies did not induce changes in locomotor activity. The results of the present study indicated that, at low doses, venlafaxine inhibited serotonin reuptake, while at higher doses it inhibited both serotonin and noradrenaline reuptake.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Venlafaxine’s effect on noradrenaline reuptake is dose-dependent, starting on doses of around 225 mg daily. When the daily dose is lower, it acts on serotonin reuptake only, like a common SSRI [36, 37].”
From Treatment of trauma-affected refugees with venlafaxine versus sertraline combined with psychotherapy - a randomised study (2016) · cites this paper as [37]
In the citing paper
“Venlafaxine is a phenylethylamine derivative inhibiting the reuptake of serotonin/5-HT; norepinephrine/NE; and to a lesser extent dopamine/DA (Bolden-Watson and Richelson, 1993; Redrobe et al., 1998).”
From Is There a Potential of Misuse for Venlafaxine and Bupropion? (2018) · cites this paper as Redrobe et al., 1998
Citations
Cites
Behavioral despair in mice: a primary screening test for antidepressants.
Porsolt, R. D., Bertin, A., & Jalfre, M. (1977) · PubMed · Cited by 4,013
Tricklebank, M. D., Forler, C., & Fozard, J. R. (1984) · European Journal of Pharmacology · doi:10.1016/0014-2999(84)90714-3 · Cited by 675
PRESYNAPTIC RECEPTORS AND THEIR ROLE IN THE REGULATION OF TRANSMITTER RELEASE.
Langer, S. Z. (1977) · Cited by 611
Functional Correlates of Serotonin 5-HT1Recognition Sites
Hoyer, D. (1988) · Journal of Receptor Research · doi:10.3109/10799898809048978 · Cited by 562
Muth, E. A., Haskins, J. T., Moyer, J. A., Husbands, G. E. M., Nielsen, S. T., & Sigg, E. B. (1986) · Biochemical Pharmacology · doi:10.1016/0006-2952(86)90769-0 · Cited by 374 · cited 2×
“Venlafaxine has not been shown to inhibit monoamine oxidase (Muth et al. 1986).”
BackgroundResult5-Hydroxytryptamine Receptor Subtypes
Peroutka, S. J. (1988) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.11.030188.000401 · Cited by 358
Behavioural despair in mice : A primary screening test for antidepressants
Porsalt, R. D. (1977) · Medical Entomology and Zoology · Cited by 332
Goodwin, G. M., De Souza, R. J., & Green, A. R. (1985) · Neuropharmacology · doi:10.1016/0028-3908(85)90153-4 · Cited by 252
Hypothermia in the rat induced by the potent serotoninergic agent 8-OH-DPAT
Hjorth, S. (1985) · Journal of Neural Transmission · doi:10.1007/bf01253058 · Cited by 241
Glennon, R. A., Naiman, N. A., Pierson, M. E., Titeler, M., Lyon, R. A., & Weisberg, E. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90212-9 · Cited by 184
Lucki, I. (1992) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(05)80055-7 · Cited by 126
Redrobe, J. P., MacSweeney, C. P., & Bourin, M. (1996) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00772-8 · Cited by 115
Self-citationTricklebank, M. D., Neill, J. C., Kidd, E. J., & Fozard, J. R. (1987) · European Journal of Pharmacology · doi:10.1016/0014-2999(87)90204-4 · Cited by 111
Bourin, M. (1990) · Fundamental & Clinical Pharmacology · doi:10.1111/j.1472-8206.1990.tb01016.x · Cited by 110
Self-citationPuech, A. J., Chermat, R., Poncelet, M., Doar�, L., & Simon, P. (1981) · Psychopharmacology · doi:10.1007/bf00433508 · Cited by 86
Mediation of the antidepressant‐like effect of 8‐OH‐DPAT in mice by postsynaptic 5‐HT1A receptors
Luscombe, G. P., Martin, K. F., Hutchins, L. J., Gosden, J., & Heal, D. J. (1993) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1993.tb12859.x · Cited by 85
Nixon, M., Hascoët, M., Bourin, M., & Colombel, M. C. (1994) · Psychopharmacology · doi:10.1007/bf02244752 · Cited by 73
Self-citationBourin, M., Hascoët, M., Colombel, M.-C., Redrobe, J. P., & Baker, G. B. (1996) · European Neuropsychopharmacology · doi:10.1016/0924-977x(96)00025-9 · Cited by 65
Self-citationAdditive effects of clonidine and antidepressant drugs in the mouse forced-swimming test
Malinge, M., Bourin, M., Colombel, M. C., & Larousse, C. (1988) · Psychopharmacology · doi:10.1007/bf02431541 · Cited by 64
Self-citationRomero, L. I., Celada, P., & Artigas, F. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90230-5 · Cited by 63
Cheetham, S. C., & Heal, D. J. (1993) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1993.tb14010.x · Cited by 61
Clonidine as a sensitizing agent in the forced swimming test for revealing antidepressant activity.
Bourin, M., Colombel, M. C., Malinge, M., & Bradwejn, J. (1991) · PubMed Central · Cited by 45
Self-citationThe additive effects of quinine on antidepressant drugs in the forced swimming test in mice
Guo, W. Y., Todd, K. G., Bourin, M., & Hascoët, M. (1995) · Psychopharmacology · doi:10.1007/bf02245627 · Cited by 35
Self-citationTHE PROFILE OF VENLAFAXINE, A NOVEL ANTIDEPRESSANT AGENT, IN BEHAVIOURAL ANTIDEPRESSANT DRUG MODELS.
Lloyd, G. K., Cronin, S., Fletcher, A., & Mitchell, P. J. (1992) · Clinical Neuropharmacology · doi:10.1097/00002826-199202001-00831 · Cited by 10
Cited by
Forced swimming test in mice: A review of antidepressant activity
Petit-Demouliere, B., Chenu, F., & Bourin, M. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2048-7 · Cited by 1,003
“…(1984), Eschalier et al. (1983), Kato et al. (1998), Luttinger et al. (1985), Malinge et al. (1988), Miura et al. (1996), Mogilnicka et al. (1987), Redrobe et al. (1998), Rogoz et al. (1999), Scotto di Tella and Mercier (1981), Stenger et al. (1987), Szymczyk and Zebrowska- Lupina (2000), Zocchi…”
Self-citationRemission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors
Thase, M. E., Entsuah, A. R., & Rudolph, R. L. (2001) · British Journal of Psychiatry · doi:10.1192/bjp.178.3.234 · Cited by 801
The olfactory bulbectomised rat as a model of depression
Song, C., & Leonard, B. E. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.010 · Cited by 698
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 551
Cryan, J. F., O'Leary, O. F., Jin, S.-H., Friedland, J. C., Ouyang, M., Hirsch, B. R., Page, M. E., Dalvi, A., Thomas, S. A., & Lucki, I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401080101 · Cited by 252
Metadata
- Authors
- Redrobe, J. P., Bourin, M., Colombel, M. C., & Baker, G. B.
- Affiliations
- Nantes Université (FR)
- Venue
- Psychopharmacology
- Published
- 1998-07-01
- Volume
- 138
- Issue
- 1
- Pages
- 1-8
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2037662525
- Cited by
- 163
- References
- 24
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2023: 7 · 2022: 3 · 2021: 4 · 2020: 4 · 2019: 4 · 2018: 4 · 2017: 7 · 2016: 9 · 2015: 8 · 2014: 7 · 2013: 9 · 2012: 11
- FWCI
- 3.17
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- venlafaxine, antidepressant effects, serotonin reuptake inhibition, norepinephrine reuptake inhibition, dose-dependent effects, forced swim test, immobility, locomotor activity, NAN-190, p-chlorophenylalanine, DSP-4, pindolol, RU 24969, 8-OH-DPAT, clonidine, lithium, quinine
- MeSH terms
- Venlafaxine Hydrochloride, Animals, Cyclohexanols, Male, Motor Activity, Pindolol, Piperazines, Selective Serotonin Reuptake Inhibitors, 8-Hydroxy-2-(di-n-propylamino)tetralin, Antidepressive Agents, Second-Generation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.